MedPath
HSA Approval

MORTIN-DS TABLET

SIN10250P

MORTIN-DS TABLET

MORTIN-DS TABLET

October 10, 1998

NAINA MOHAMED & SONS PRIVATE LIMITED

NAINA MOHAMED & SONS PRIVATE LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantNAINA MOHAMED & SONS PRIVATE LIMITED
Licence HolderNAINA MOHAMED & SONS PRIVATE LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

J01EE01

sulfamethoxazole and trimethoprim

Manufacturer Information

NAINA MOHAMED & SONS PRIVATE LIMITED

MICRO LABS LTD

Active Ingredients

TRIMETHOPRIM

160 mg

Trimethoprim

SULPHAMETHOXAZOLE

800 mg

Sulfamethoxazole

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

MORTIN-DS TABLET - HSA Approval | MedPath